Page 766 - Clinical Application of Mechanical Ventilation

732 Index

Pressure support ventilation (PSV) (continued) Pulmonary vascular resistance (PVR), 293, 698
assist breaths during, 338 Pulse contour analysis, 295–296
characteristics of, 337f Pulse Contour Cardiac Output (PiCCO), 296
dyssynchrony during, 351–352 Pulse oximeter, 258
effects of changing compliance and airflow resistance, Pulse oximetry, 194, 258
338f accuracy and clinical use of, 259
inverse ratio, 338–340 applications of, 259t
and lung characteristics, 343–345 factors affecting accuracy of, 260t
neonatal, 553 integrated pulse CO-oximetry, 259–260
waveforms developed during, 337–340 limitations of, 259
Pressure-limited flow-cycled breaths, 68–69 Pulse pressure, 279–280
Pressure-limited time-cycled breaths, 68 Pulsus paradoxus, 31
Pressure-regulated volume control (PRVC), 68, 107–108, Puritan Bennett 840, 69, 108
107t, 566 Puritan-Bennett suction regulator, 174f
Pressure-time waveform, 314–317, 318t, 319f, 320f, 321f
as diagnostic tool, 352–357, 353f Q
effects of flow, circuit, and lung characteristics on,
326–328, 326f Q s /Q t , 521
Pressure-triggered mechanism, 60–61, 61f Quelicin, 434t, 437t
Pressure-volume loop (PVL), 5, 5f, 8–9, 9f, 311, 359, 360f QVAR, 429t
and airflow resistance, 361 R
lower inflection point on, 361–362, 362f
and lung-thorax compliance, 360–361, 360f Racemic epinephrine, 425t
upper inflection point on, 363, 363f Radiopaque, 160
Prone positioning (PP), 409–410, 409t, 496 Rain-out, 554
Prophylactic ventilatory support, 214, 218, 219t Ramp, 204
Propofol (Diprivan), 449 Rapid sequence intubation (RSI), 168–170
Proportional assist ventilation (PAV), 69, 105–106, 106t indications and contraindications, 168, 169t
Pseudomonas aeruginosa, 476 practice guidelines, 169–170, 169f
PSV. See Pressure support ventilation (PSV) Rapid shallow breathing index (RSBI), 179, 526
PtcCO 2 , 266 Reabsorption, 37–38
PtcO 2 , 265–266 Recruitment maneuver, 495–496, 497t
Pulmonary arterial pressure waveform, 286, 287f, 288f Rectangular waveform, 72f, 74f
Pulmonary artery catheter, 284–292 Refractory hypoxemia, 6, 14, 88
and cardiac output, 291–292 Reintubation, clinical predictors for, 181t
insertion of, 285–286 Renal failure
position of, 286f effects on drug clearance, 36–38
verification of wedged position, 291 indicators of, 36, 37t
Pulmonary artery pressure (PAP), 35, 285 Renal function, alterations of, 90
conditions affecting, 288t Renal perfusion, 35
measurement, 286–289 Resistance, 53
and positive pressure ventilation, 288, 289f Resistance load, 52–53
Pulmonary blood flow, 32–34, 382 Respiratory acidosis, 42–43, 255, 387, 387t
Pulmonary capillary wedge pressure (PCWP), 35, 285, Respiratory alkalosis, 43t, 387–388, 388t
289–291 Respiratory care calculations, 689–700
conditions affecting, 290t Respiratory distress syndrome (RDS), 548
measurement, 290 Respiratory drive, depressed, 18, 19t
Pulmonary capillary wedge pressure (PCWP) waveform, Respiratory fatigue, 255
289–290, 290f Respiratory frequency, 244–245
Pulmonary edema, 290, 402, 602 Respiratory mechanics measurement, 350–351
Pulmonary hypertension, 286–287 Respiratory muscle fatigue, 533–534
Pulmonary measurements, 520t, 524–526 Respiratory muscle strength, 99
Pulmonary reserve, 520t, 524 Resting energy expenditure (REE), 42, 407, 408t

Copyright 2013 Cengage Learning. All Rights Reserved. May not be copied, scanned, or duplicated, in whole or in part. Due to electronic rights, some third party content may be suppressed from the eBook and/or eChapter(s).
Editorial review has deemed that any suppressed content does not materially affect the overall learning experience. Cengage Learning reserves the right to remove additional content at any time if subsequent rights restrictions require it.